Subject(s)
Anti-Bacterial Agents/administration & dosage , Aorta, Thoracic/surgery , Aortic Aneurysm, Thoracic , Blood Vessel Prosthesis Implantation , Hemothorax , Pleurisy , Surgical Wound Infection , Acinetobacter baumannii/isolation & purification , Aged , Aorta, Thoracic/pathology , Aortic Aneurysm, Thoracic/diagnostic imaging , Aortic Aneurysm, Thoracic/physiopathology , Aortic Aneurysm, Thoracic/surgery , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/methods , Combined Modality Therapy , Enterobacter cloacae/isolation & purification , Female , Hemothorax/etiology , Hemothorax/physiopathology , Hemothorax/surgery , Humans , Pleurisy/etiology , Pleurisy/physiopathology , Pleurisy/therapy , Radiography , Reoperation/methods , Severity of Illness Index , Surgical Wound Infection/etiology , Surgical Wound Infection/physiopathology , Surgical Wound Infection/surgery , Treatment OutcomeABSTRACT
4023 operations on account of primary bronchopulmonary cancer were performed in the period of 1963--2006 years. Rare malignant tumors (carcinoid, adenocystic cancer, sarcoma, large cell carcinoma etc.) were diagnosed in 379 (9,1%) cases. 275 patients of those had bronchpulmonary carcinoid; adenocystic cancer was diagnosed in 26 patients; 67 had various types of non-epithelial malignant tumors and 11 had a large cell carcinoma. All patients were operated on, morphological verification was obtained in all cases. The surgical tactics in patients with rare malignant tumours should be the same as for non-small cell lung--lobectomy of pneumonectomy with lyphadenectomy. The long term follow-up results witness the advisability of surgical treatment.
Subject(s)
Lung Neoplasms/surgery , Pneumonectomy/methods , Adolescent , Adult , Aged , Child , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Lung Neoplasms/diagnosis , Lymph Node Excision/methods , Male , Middle Aged , Rare Diseases , Retrospective Studies , Treatment Outcome , Young AdultABSTRACT
Thoracic units perform plastic operations on the bronchi in 5-10% of all radical interventions for lung cancer. This figure was 7.5% at our unit. A total of 184 patients were operated on, with a mortality rate of 9.7% (18 patients died). Lobectomy with circulatory resection of the main bronchus is the optimal plastic operation on the bronchi in lung cancer. Long-term results following bronchial resection and plastic repair suggest the oncological rationale for these operations. These operations make it possible to preserve functionally significant lung tissue, thus assuring the high quality of life in the patient.
Subject(s)
Bronchi/surgery , Lung Neoplasms/surgery , Plastic Surgery Procedures/methods , Pneumonectomy/methods , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Quality of Life , Retrospective Studies , Time Factors , Treatment OutcomeABSTRACT
The authors discuss their experience in the treatment of 18 patients who were operated on for a second time due to the development of a recurrent tumor. A true and false recurrence was distinguished. The causes of their development were: diagnostic errors in 6, malignancy of the adenoma in 4, and technical faults during the operation in 8 patients. Various types of repeated interventions were conducted in in all 18 patients, preference was given to reconstructive-plastic operations. There were no fatal outcomes. Fourteen patients have a survival period of 5 months to 17 years, four patients with malignant carcinoid died from metastases.
Subject(s)
Adenoma/surgery , Bronchial Neoplasms/surgery , Carcinoid Tumor/surgery , Carcinoma, Adenoid Cystic/surgery , Neoplasm Recurrence, Local/surgery , Adenoma/mortality , Adult , Bronchial Neoplasms/mortality , Carcinoid Tumor/mortality , Carcinoma, Adenoid Cystic/mortality , Female , Humans , Male , Middle Aged , ReoperationABSTRACT
The results of repeat surgery for pulmonary metastases in 17 cases are discussed. The study was based on the data of 38 repeated interventions for metastases following lung resection for cancer, bilateral metastases and recurrent pulmonary metastases. All surgery was carried out as a component of combined treatment including chemotherapy and radiation. It was intended to increase the effect of chemotherapy by cutting down the size of tumor. Surgery was not performed unless lesions were limited in number (solitary metastases) and when there were local recurrences of primary tumor or distant metastases to other organs. The extent of resection should be as limited as possible to preserve lung tissue. It is increased of necessity in cases of repeat removal of metastases from the same lung; lobectomy or pulmonectomy is indicated in such cases. Both short- and long-term results show good tolerance of surgery by patients, low incidence of complications and longer survival when patients are supported by chemo- or chemoradiation treatment.
